Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Primary Sclerosing Cholangitis industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Gilead Sciences, Inc
Conatus Pharmaceuticals, Inc
Mylan NV
Acorda Therapeutics, Inc
Sirnaomics, Inc
Teva Pharmaceuticals Industries Ltd
ALLERGAN
Glenmark
Impax Laboratories, LLC
Intercept Pharmaceuticals, Inc
Takeda Pharmaceutical Company Limited
DURECT CORPORATION
Dr Falk Pharma GmbH
By Type:
Obeticholic Acid
Corticosteroids
Methotrexate
Others
Ursodeoxycholic Acid
By Application:
Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Primary Sclerosing Cholangitis Market Overview 2018-2029
-
1.1 China Primary Sclerosing Cholangitis Industry Development Overview
-
1.2 China Primary Sclerosing Cholangitis Industry Development History
-
1.3 China Primary Sclerosing Cholangitis Industry Market Size (2018-2029)
-
1.4 China Primary Sclerosing Cholangitis Market Analysis by Type from Production Side
-
1.4.1 China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Obeticholic Acid (2018-2029)
-
1.4.2 China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Corticosteroids (2018-2029)
-
1.4.3 China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Methotrexate (2018-2029)
-
1.4.4 China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.5 China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Ursodeoxycholic Acid (2018-2029)
-
1.5 China Primary Sclerosing Cholangitis Market Analysis by Application from Consumption End
-
1.5.1 China Primary Sclerosing Cholangitis Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.5.2 China Primary Sclerosing Cholangitis Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.3 China Primary Sclerosing Cholangitis Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.6 China Primary Sclerosing Cholangitis Market Analysis by Region
-
1.6.1 North China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
Chapter 2 China Primary Sclerosing Cholangitis Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Primary Sclerosing Cholangitis Market Status and Competition at home and abroad in 2023
-
2.2.2 China Primary Sclerosing Cholangitis Market Status and Competition Analysis in 2023
-
2.2.3 China Primary Sclerosing Cholangitis Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Primary Sclerosing Cholangitis Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Primary Sclerosing Cholangitis Industry Development
Chapter 3 Primary Sclerosing CholangitisIndustry Chain Analysis
-
3.1 Primary Sclerosing Cholangitis Industry Chain
-
3.2 Primary Sclerosing Cholangitis Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Primary Sclerosing Cholangitis Market
-
3.3 Primary Sclerosing Cholangitis Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Primary Sclerosing Cholangitis Market
Chapter 4 China Primary Sclerosing Cholangitis Market, by Type
-
4.1 China Primary Sclerosing Cholangitis Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Primary Sclerosing Cholangitis Total Production Volume and Growth Rate from Production Side
-
4.5 China Primary Sclerosing Cholangitis Production Volume and Growth Rate, by Type
-
4.5.1 China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Obeticholic Acid
-
4.5.2 China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Corticosteroids
-
4.5.3 China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Methotrexate
-
4.5.4 China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Others
-
4.5.5 China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Ursodeoxycholic Acid
Chapter 5 China Primary Sclerosing Cholangitis Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Primary Sclerosing Cholangitis Total Market Size and Growth Rate from Consumption End
-
5.5 China Primary Sclerosing Cholangitis Market Size and Growth Rate, by Application
-
5.5.1 China Primary Sclerosing Cholangitis Market Size and Growth Rate of Online Pharmacies
-
5.5.2 China Primary Sclerosing Cholangitis Market Size and Growth Rate of Hospital Pharmacies
-
5.5.3 China Primary Sclerosing Cholangitis Market Size and Growth Rate of Retail Pharmacies
Chapter 6 China Primary Sclerosing Cholangitis Market, by Region
-
6.1 China Primary Sclerosing Cholangitis Production Volume and Production Value, by Region
-
6.2 China Primary Sclerosing Cholangitis Sales Volume and Sales Value, by Region
Chapter 7 North China Primary Sclerosing Cholangitis Market Analysis
-
7.1 North China Primary Sclerosing Cholangitis Market, by Type
-
7.2 North China Primary Sclerosing Cholangitis Market, by Application
Chapter 8 Central China Primary Sclerosing Cholangitis Market Analysis
-
8.1 Central China Primary Sclerosing Cholangitis Market, by Type
-
8.2 Central China Primary Sclerosing Cholangitis Market, by Application
Chapter 9 South China Primary Sclerosing Cholangitis Market Analysis
-
9.1 South China Primary Sclerosing Cholangitis Market, by Type
-
9.2 South China Primary Sclerosing Cholangitis Market, by Application
Chapter 10 East China Primary Sclerosing Cholangitis Market Analysis
-
10.1 East China Primary Sclerosing Cholangitis Market, by Type
-
10.2 East China Primary Sclerosing Cholangitis Market, by Application
Chapter 11 Northeast China Primary Sclerosing Cholangitis Market Analysis
-
11.1 Northeast China Primary Sclerosing Cholangitis Market, by Type
-
11.2 Northeast China Primary Sclerosing Cholangitis Market, by Application
Chapter 12 Southwest China Primary Sclerosing Cholangitis Market Analysis
-
12.1 Southwest China Primary Sclerosing Cholangitis Market, by Type
-
12.2 Southwest China Primary Sclerosing Cholangitis Market, by Application
Chapter 13 Northwest China Primary Sclerosing Cholangitis Market Analysis
-
13.1 Northwest China Primary Sclerosing Cholangitis Market, by Type
-
13.2 Northwest China Primary Sclerosing Cholangitis Market, by Application
Chapter 14 Company Profiles
-
14.1 Gilead Sciences, Inc
-
14.1.1 Gilead Sciences, Inc Company Profile
-
14.1.2 Gilead Sciences, Inc Primary Sclerosing Cholangitis Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Conatus Pharmaceuticals, Inc
-
14.2.1 Conatus Pharmaceuticals, Inc Company Profile
-
14.2.2 Conatus Pharmaceuticals, Inc Primary Sclerosing Cholangitis Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Mylan NV
-
14.3.1 Mylan NV Company Profile
-
14.3.2 Mylan NV Primary Sclerosing Cholangitis Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Acorda Therapeutics, Inc
-
14.4.1 Acorda Therapeutics, Inc Company Profile
-
14.4.2 Acorda Therapeutics, Inc Primary Sclerosing Cholangitis Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sirnaomics, Inc
-
14.5.1 Sirnaomics, Inc Company Profile
-
14.5.2 Sirnaomics, Inc Primary Sclerosing Cholangitis Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Teva Pharmaceuticals Industries Ltd
-
14.6.1 Teva Pharmaceuticals Industries Ltd Company Profile
-
14.6.2 Teva Pharmaceuticals Industries Ltd Primary Sclerosing Cholangitis Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 ALLERGAN
-
14.7.1 ALLERGAN Company Profile
-
14.7.2 ALLERGAN Primary Sclerosing Cholangitis Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Glenmark
-
14.8.1 Glenmark Company Profile
-
14.8.2 Glenmark Primary Sclerosing Cholangitis Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Impax Laboratories, LLC
-
14.9.1 Impax Laboratories, LLC Company Profile
-
14.9.2 Impax Laboratories, LLC Primary Sclerosing Cholangitis Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Intercept Pharmaceuticals, Inc
-
14.10.1 Intercept Pharmaceuticals, Inc Company Profile
-
14.10.2 Intercept Pharmaceuticals, Inc Primary Sclerosing Cholangitis Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Takeda Pharmaceutical Company Limited
-
14.11.1 Takeda Pharmaceutical Company Limited Company Profile
-
14.11.2 Takeda Pharmaceutical Company Limited Primary Sclerosing Cholangitis Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 DURECT CORPORATION
-
14.12.1 DURECT CORPORATION Company Profile
-
14.12.2 DURECT CORPORATION Primary Sclerosing Cholangitis Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Dr Falk Pharma GmbH
-
14.13.1 Dr Falk Pharma GmbH Company Profile
-
14.13.2 Dr Falk Pharma GmbH Primary Sclerosing Cholangitis Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Primary Sclerosing Cholangitis Industry Research Conclusions
-
15.2 Primary Sclerosing Cholangitis Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Primary Sclerosing Cholangitis Industry Market Size (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Obeticholic Acid (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Corticosteroids (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Methotrexate (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Production Volume, Production Value and Growth Rate of Ursodeoxycholic Acid (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Primary Sclerosing Cholangitis Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure North China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
Figure Central China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
Figure South China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
Figure East China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Primary Sclerosing Cholangitis Market Size and Growth Rate from 2018-2029
-
Figure Primary Sclerosing Cholangitis Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Primary Sclerosing Cholangitis Market Share by Type in 2018
-
Figure China Primary Sclerosing Cholangitis Market Share by Type in 2023
-
Figure China Primary Sclerosing Cholangitis Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Obeticholic Acid (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Corticosteroids (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Methotrexate (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Production Volume and Growth Rate of Ursodeoxycholic Acid (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Market Share by Application in 2018
-
Figure China Primary Sclerosing Cholangitis Market Share by Application in 2023
-
Figure China Primary Sclerosing Cholangitis Total Market Size and Growth Rate from Consumption End
-
Figure China Primary Sclerosing Cholangitis Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Table China Primary Sclerosing Cholangitis Production Volume by Region (2018-2023)
-
Table China Primary Sclerosing Cholangitis Production Volume Share by Region (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Production Volume Share by Region (2018-2023)
-
Table China Primary Sclerosing Cholangitis Production Value by Region (2018-2023)
-
Table China Primary Sclerosing Cholangitis Production Value Share by Region (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Production Value Share by Region (2018-2023)
-
Table China Primary Sclerosing Cholangitis Sales Volume by Region (2018-2023)
-
Table China Primary Sclerosing Cholangitis Sales Volume Share by Region (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Sales Volume Share by Region (2018-2023)
-
Table China Primary Sclerosing Cholangitis Sales Value by Region (2018-2023)
-
Table China Primary Sclerosing Cholangitis Sales Value Share by Region (2018-2023)
-
Figure China Primary Sclerosing Cholangitis Sales Value Share by Region (2018-2023)
-
Table North China Primary Sclerosing Cholangitis Production Volume by Type (2018-2023)
-
Table North China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Figure North China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Table North China Primary Sclerosing Cholangitis Sales Volume by Application (2018-2023)
-
Table North China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Figure North China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Table Central China Primary Sclerosing Cholangitis Production Volume by Type (2018-2023)
-
Table Central China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Figure Central China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Table Central China Primary Sclerosing Cholangitis Sales Volume by Application (2018-2023)
-
Table Central China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Figure Central China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Table South China Primary Sclerosing Cholangitis Production Volume by Type (2018-2023)
-
Table South China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Figure South China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Table South China Primary Sclerosing Cholangitis Sales Volume by Application (2018-2023)
-
Table South China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Figure South China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Table East China Primary Sclerosing Cholangitis Production Volume by Type (2018-2023)
-
Table East China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Figure East China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Table East China Primary Sclerosing Cholangitis Sales Volume by Application (2018-2023)
-
Table East China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Figure East China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Table Northeast China Primary Sclerosing Cholangitis Production Volume by Type (2018-2023)
-
Table Northeast China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Figure Northeast China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Table Northeast China Primary Sclerosing Cholangitis Sales Volume by Application (2018-2023)
-
Table Northeast China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Table Southwest China Primary Sclerosing Cholangitis Production Volume by Type (2018-2023)
-
Table Southwest China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Figure Southwest China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Table Southwest China Primary Sclerosing Cholangitis Sales Volume by Application (2018-2023)
-
Table Southwest China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Table Northwest China Primary Sclerosing Cholangitis Production Volume by Type (2018-2023)
-
Table Northwest China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Figure Northwest China Primary Sclerosing Cholangitis Production Volume Share by Type (2018-2023)
-
Table Northwest China Primary Sclerosing Cholangitis Sales Volume by Application (2018-2023)
-
Table Northwest China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Primary Sclerosing Cholangitis Sales Volume Share by Application (2018-2023)
-
Table Gilead Sciences, Inc Company Profile
-
Table Gilead Sciences, Inc Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Conatus Pharmaceuticals, Inc Company Profile
-
Table Conatus Pharmaceuticals, Inc Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Mylan NV Company Profile
-
Table Mylan NV Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Acorda Therapeutics, Inc Company Profile
-
Table Acorda Therapeutics, Inc Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Sirnaomics, Inc Company Profile
-
Table Sirnaomics, Inc Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceuticals Industries Ltd Company Profile
-
Table Teva Pharmaceuticals Industries Ltd Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table ALLERGAN Company Profile
-
Table ALLERGAN Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Glenmark Company Profile
-
Table Glenmark Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Impax Laboratories, LLC Company Profile
-
Table Impax Laboratories, LLC Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Intercept Pharmaceuticals, Inc Company Profile
-
Table Intercept Pharmaceuticals, Inc Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Company Limited Company Profile
-
Table Takeda Pharmaceutical Company Limited Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table DURECT CORPORATION Company Profile
-
Table DURECT CORPORATION Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
Table Dr Falk Pharma GmbH Company Profile
-
Table Dr Falk Pharma GmbH Primary Sclerosing Cholangitis Revenue, Price and Gross (2018-2023)
-
